Market Overview

UPDATE: Citigroup Downgrades Bemis to Neutral on Earnings Risk

Share:
Related BMS
Benzinga's Top Upgrades, Downgrades For September 15, 2017
Wall Street's M&A Chatter From September 7: Amcor-Bemis, NuVasive-Vertera Spine, Newell-Chesapeake Bay Candle

Citigroup reduced its rating on Bemis (NYSE: BMS) from Buy to Neutral and lowered its price target from $36 to $34.

Citigroup noted, "We are assuming coverage of BMS with a Neutral rating, downgrading from Citi's previous Buy rating. While the company has the potential to significantly grow cash in 2013-14 through optimization of its asset base, sluggish volume growth and commodity inflation in the food markets BMS is exposed to creates earnings risk."

Bemis closed at $30.48 on Monday.

Latest Ratings for BMS

DateFirmActionFromTo
Sep 2017Bank of AmericaUpgradesUnderperformNeutral
Jul 2017UBSInitiates Coverage OnBuy
Jun 2017BarclaysUpgradesEqual-WeightOverweight

View More Analyst Ratings for BMS
View the Latest Analyst Ratings

Posted-In: CitigroupAnalyst Color Downgrades Intraday Update Analyst Ratings

 

Related Articles (BMS)

View Comments and Join the Discussion!
Loading...

Partner Center

Loading...